Medicale Corp
MCLE · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $2 | $2 |
| Gross Profit | $0 | $0 | -$2 | -$2 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $55 | $38 | $44 | $32 |
| SG&A Expenses | $55 | $38 | $44 | $32 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $55 | $38 | $44 | $32 |
| Operating Income | -$55 | -$38 | -$44 | -$32 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$4 | $0 | $0 | $0 |
| Pre-Tax Income | -$58 | -$38 | -$44 | -$32 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$58 | -$37 | -$46 | -$32 |
| % Margin | – | – | – | – |
| EPS | -0.01 | -0.006 | -0.008 | -0.005 |
| % Growth | -53.1% | 17.9% | -44.4% | – |
| EPS Diluted | -0.01 | -0.006 | -0.008 | -0.005 |
| Weighted Avg Shares Out | 5,920 | 5,920 | 5,920 | 5,920 |
| Weighted Avg Shares Out Dil | 5,920 | 5,920 | 5,920 | 5,920 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $4 | $0 | $0 | $0 |
| Depreciation & Amortization | $55 | $38 | $2 | $2 |
| EBITDA | $0 | $0 | -$42 | -$30 |
| % Margin | – | – | – | – |